SkinVision Achieves EU MDR Class IIa Certification for Skin Cancer Detection App
SkinVision, a leading skin cancer detection app based in the Netherlands, recently received the prestigious EU Medical Device Regulation (MDR) Class IIa certification, the highest standard for medical devices. This achievement highlights the app’s commitment to safety, reliability, and effectiveness, showcasing the potential of AI in healthcare. Unlike traditional medical devices, SkinVision is a mobile app that allows users to self-check their skin anytime and anywhere, marking a significant advancement in digital health solutions.
With projections indicating rising skin cancer cases in the UK, SkinVision aims to lower barriers to access through partnerships with over 30 organizations and insurance options for more than 20 million individuals. The app has facilitated over six million skin checks globally, empowering users to monitor their skin health effectively. By meeting stringent medical standards, SkinVision not only raises the bar for health apps but also paves the way for broader adoption of AI-driven medical technologies.
